Meningococcal Vaccine Market Growth - Size 2021 to 2031
Meningococcal Vaccine Market Report Analysis
Meningococcal Vaccine Market
-
CAGR (2025 - 2031)6.0% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- PFIZER INC
- NOVARTIS AG
- SANOFI
- SERUM INSTITUTE OF INDIA LTD
- GLAXOSMITHKLINE PLC
- MERCK AND CO INC
- HUALAN BIOLOGICAL ENGINEERING INC
- INCEPTA PHARMACEUTICALS LTD
- WALVAX BIOTECHNOLOGY CO LTD
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Type
- Bivalent
- Quadrivalent
- Others
By Brand
- Menactra
- Menveo
- Bexsero
- Trumenba
- Nimenrix
- Others
Get Free Sample For